(Q39596000)

English

Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia

scientific article published on 8 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

based on heuristic

inferred from title

author name string

Juana Serrano-López

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Joaquin Sanchez-Garcia

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Josefina Serrano

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Miguel A Alvarez-Rivas

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jose M Garcia-Castellano

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jose Roman-Gomez

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Olga de la Rosa

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Concepcion Herrera-Arroyo

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Antonio Torres-Gomez

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

8 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1546-1555

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Acute myeloid leukemia and the position of autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Dendritic cells as therapeutic vaccines against cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Manipulating dendritic cell biology for the active immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Characterization of human blood dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Developmental origin of pre-DC2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Chemotherapy plus G-CSF mobilized peripheral blood stem cell harvests from acute myeloid leukaemia patients contain large amounts of polyclonal myeloid linnegCD11cpos dendritic precursor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Inhibiting effects on the induction of cytotoxic T lymphocytes by dendritic cells pulsed with lysates from acute myeloid leukemia blasts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03042.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2010.03042.X

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39596000&oldid=1843240426"